NJDTHi001-A            
            
        General
Donor Information
| General Donor Information | |
| Sex | male | 
| Ethnicity | Han | 
| Phenotype and Disease related information (Donor) | |
| Diseases | A disease was diagnosed. | 
| External Databases (Donor) | |
| BioSamples | SAMEA7346333 | 
Ethics
| Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? | Yes | 
| Was the consent voluntarily given? | Yes | 
| Has the donor been informed that participation will not directly influence their personal treatment? | Yes | 
| Can you provide us with a copy of the Donor Information Sheet provided to the donor? | Yes | 
| Do you (Depositor/Provider) hold the original Donor Consent Form? | Yes | 
| Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. | anonymised | 
| Does consent explicitly allow the derivation of pluripotent stem cells? | Yes | 
| Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? | Yes | 
| How may genetic information associated with the cell line be accessed? | Controlled Access | 
| Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? | No | 
| Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | No | 
| Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? | Yes | 
| Name of accrediting authority involved? | Ethics Committee of Nanjing Drum Tower Hospital | 
| Approval number | 2016-151-01 | 
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? | 
hIPSC Derivation
| General | |
| Source cell type | A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes. Synonyms 
 | 
| Collected in | 2020 | 
| Reprogramming method | |
| Vector type | Non-integrating | 
| Vector | Sendai virus | 
| Vector free reprogramming | |
| Other | |
| Derived under xeno-free conditions | Unknown | 
| Derived under GMP? | Yes | 
| Available as clinical grade? | Yes | 
Culture Conditions
| Surface coating | Matrigel/Geltrex | 
| Medium | mTeSR™ 1 | 
Characterisation
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles | 
| NANOG | Yes | |||||
| SSEA-4 | Yes | |||||
| POU5F1 (OCT-4) | Yes | 
| Marker | Present | Absent | 
| mCpG | ||
| OCT4 | X | 
Report
						Morphology pictures
Differentiation Potency
In vitro directed differentiation
					| Marker | Expressed | 
| PAX6 | Yes | 
Morphology
In vitro directed differentiation
					| Marker | Expressed | 
| TBXT | Yes | 
Morphology
In vitro directed differentiation
					| Marker | Expressed | 
| AFP | Yes | 
Morphology
Genotyping
| Karyotyping (Cell Line) | |
| Has the cell line karyotype been analysed? | Yes 
												46 XY
											 | 
| Other Genotyping (Cell Line) | |

Login to share your feedback, experiences or results with the research community.